CN216629424U - Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument - Google Patents
Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument Download PDFInfo
- Publication number
- CN216629424U CN216629424U CN202122878292.7U CN202122878292U CN216629424U CN 216629424 U CN216629424 U CN 216629424U CN 202122878292 U CN202122878292 U CN 202122878292U CN 216629424 U CN216629424 U CN 216629424U
- Authority
- CN
- China
- Prior art keywords
- pulse
- circuit board
- pulse circuit
- key
- wearable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000019695 Migraine disease Diseases 0.000 title claims abstract description 29
- 206010027599 migraine Diseases 0.000 title claims abstract description 29
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 19
- 230000000638 stimulation Effects 0.000 title claims abstract description 14
- 210000005036 nerve Anatomy 0.000 title claims description 12
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 claims abstract description 17
- 230000007246 mechanism Effects 0.000 claims abstract description 12
- 238000011282 treatment Methods 0.000 claims description 17
- 230000002457 bidirectional effect Effects 0.000 claims description 3
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract description 8
- 229920001184 polypeptide Polymers 0.000 abstract description 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 8
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 8
- 210000004556 brain Anatomy 0.000 abstract description 5
- 230000000202 analgesic effect Effects 0.000 abstract description 4
- 229960005181 morphine Drugs 0.000 abstract description 4
- 210000002569 neuron Anatomy 0.000 abstract description 4
- 210000001061 forehead Anatomy 0.000 abstract 1
- 210000003901 trigeminal nerve Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 208000000112 Myalgia Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- RXKMOPXNWTYEHI-RDRKJGRWSA-N Flunarizine hydrochloride Chemical compound Cl.Cl.C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 RXKMOPXNWTYEHI-RDRKJGRWSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 229960002807 flunarizine hydrochloride Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Landscapes
- Electrotherapy Devices (AREA)
Abstract
The utility model relates to the technical field of medical instruments and discloses a wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus, which comprises a control module and an electrode mechanism, wherein the electrode mechanism is positioned at the lower side of the control module; the control module comprises a main body shell, a pulse circuit board, a pulse controller and a wireless communication module, wherein the pulse circuit board is fixedly arranged in the main body shell. The wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus is wearable on the body, is convenient to carry, can also install corresponding APP and small programs in a portable terminal such as a mobile phone and the like, controls the equipment of the utility model through the APP and the small programs, for example, controls the frequency, the width, the waveform and the like of pulses emitted by the equipment, is convenient to use, stimulates the forehead and trigeminal nerves by certain low-frequency pulse electrical stimulation, can activate morphine polypeptide neurons in the brain, and causes the release of endogenous morphine-like polypeptides to generate an analgesic effect.
Description
Technical Field
The utility model relates to the technical field of medical instruments, in particular to a wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus.
Background
Migraine is the most common disability-causing disease ranked seventh globally, migraine cannot be cured, but medicines and other treatments help to relieve or reduce the occurrence of migraine, the migraine is treated by taking medicines immediately at the beginning of symptoms, the use of the medicines is determined according to the severity of the carbuncle on the head, accompanying symptoms, the prior medication condition and the individual condition of a patient, the medicine treatment has slow effect and is accompanied by side effects, the cost of the patient is high, the migraine treated by percutaneous nerve electrical stimulation is better than single oral flunarizine hydrochloride, and the intracranial cerebral blood flow speed improved by the percutaneous nerve electrical stimulation is better than single oral flunarizine.
The low-frequency therapeutic apparatus has the functions of exciting motor nerves and sensory nerves, relieving pain, improving blood circulation and regulating autonomic nerves, is most important for reconstructing the damaged function of the motor nervous system, stimulates local muscles, nerves and blood vessels by low-frequency current, promotes the blood circulation, increases the blood supply and oxygen supply of local tissues, can generate tremor and muscle vibration when the acupuncture points and pain points are stimulated by the low-frequency current, excites coarse fibers, closes a gate for conducting pain, improves a pain valve, and releases endogenous morphine-like substances to play a role in relieving pain, and patients with hemiplegia and cerebral trauma can relieve muscle spasm by repeated low-frequency electrical stimulation and reestablish a neural network in a cortex to reconstruct lost functions and restore the motion function of paralyzed limbs, and is based on the traditional Chinese medicine meridian theory, is combined with the modern electronic technology of the brain, and utilizes pulse waveforms to stimulate the acupuncture points of a human body to achieve treatment, the medical equipment for health care purpose, the existing low-frequency pulse therapeutic equipment mostly adopts the traditional portable or handheld type, is inconvenient to use, has no wireless communication function, and does not support the direct control of external equipment.
SUMMERY OF THE UTILITY MODEL
Technical problem to be solved
The utility model aims to provide a wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus, and aims to solve the problems that most of the existing low-frequency pulse therapeutic apparatuses in the background art adopt a traditional portable or handheld type, are inconvenient to use, have no wireless communication function, and do not support direct control of external equipment.
(II) technical scheme
In order to achieve the purpose, the utility model provides the following technical scheme: the wearable transcutaneous nerve electrical stimulation migraine therapeutic apparatus comprises a control module and an electrode mechanism, wherein the electrode mechanism is positioned at the lower side of the control module;
the control module comprises a main body shell, a pulse circuit board, a pulse controller and a wireless communication module, wherein the pulse circuit board is fixedly installed in the main body shell, and the pulse circuit board and the pulse controller are installed at the upper end of the pulse circuit board.
Preferably, the pulse controller is integrated with a wireless communication module, the wireless communication module is a bluetooth communication module, and the device of the present invention can be controlled by an external device through a wireless communication channel, for example, a corresponding APP and an applet can be installed in a portable terminal such as a mobile phone, and the device of the present invention can be controlled by the APP and the applet, for example, the frequency, the width, the waveform, and the like of a pulse transmitted by the control device.
Preferably, the electrode mechanism comprises an electrode plate, connector contacts and an electrode protection film, the connector contacts are arranged on the front surface of the electrode plate, the connector contacts correspond to a pulse emitting area of the electrode plate, medical conductive gel is arranged on the pulse emitting area, the electrode plate is a PET electrode plate, two button-type connector contacts for emitting pulses are arranged on the front surface of the electrode plate, the medical conductive gel is attached to the skin of a human body when in use, the area is an area for emitting pulses, and the covered muscle area is an effective treatment area, wherein the pulse emitting contacts and the pulse emitting areas are not limited to the number specifically described above and can be other numbers, the electrode plate has extremely small conductive resistance, the conductivity is good, the skin and muscle textures of the human body can be better attached, and the attachment of the device of the utility model to the human body is ensured, thereby more effectively treating.
Preferably, the electrode protection film is positioned on the back of the electrode plate, the electrode protection film is tightly attached to the electrode plate, and the installed electrode protection film is used for protecting gel below the electrode plate.
Preferably, the frequency of the pulse controller transmitting pulse circuit is within the range of 2-160Hz, the pulse controller transmitting pulse circuit is a bidirectional square wave electric wave with the width of 9-350us, and certain low-frequency pulse electric stimulation can activate morphine polypeptide neurons in the brain to cause the release of endogenous morphine-like polypeptides so as to generate an analgesic effect.
Preferably, the control module further comprises a first key, a status indicator lamp, a second key, a third key and a reset hole, the first key is mounted at the upper end of the main body shell, the status indicator lamp is located at the inner side of the first key, the power-on and power-off are controlled through the first key, the status indicator lamp can indicate each status of the wearable transcutaneous electrical nerve stimulation migraine treatment device, and the indicator lamp can be turned on when the wearable transcutaneous electrical nerve stimulation migraine treatment device is powered on; when relieving muscle pain, the indicator light can be strobed; when the power-off is performed, the indicator light can be turned off, and when the power-on is performed, the indicator light changes color.
Preferably, the second key is arranged on the side of the main body casing, the third key is arranged on the side of the main body casing, and the pulse intensity is adjusted through the second key and the third key.
Preferably, the first button is electrically connected with the pulse circuit board, the status indicator lamp is electrically connected with the pulse circuit board, the second button is electrically connected with the pulse circuit board, the third button is electrically connected with the pulse circuit board, the reset hole is electrically connected with the pulse circuit board, the connector contact is electrically connected with the pulse circuit board, and the complete power supply of the equipment is ensured by the arrangement.
Compared with the prior art, the utility model has the beneficial effects that:
1. the wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus can be worn on the body, is convenient to carry, can also install corresponding APP and small programs in a portable terminal such as a mobile phone and the like, and controls the equipment of the utility model through the APP and the small programs, for example, the frequency, the width, the waveform and the like of the pulse emitted by the control equipment are convenient to use;
2. the wearable transcutaneous nerve electrical stimulation migraine therapeutic apparatus has the advantages that the pulse circuit emits pulses with the frequency within the range of 2-160Hz and the pulse width within the range of 9-350us, and certain low-frequency pulse electrical stimulation can activate morphine polypeptide neurons in the brain to cause the release of endogenous morphine-like polypeptides to generate an analgesic effect;
3. the electrode plate of the wearable percutaneous nerve electrical stimulation migraine therapeutic apparatus has extremely low conductive resistance and good conductive performance, and can be better attached to the skin and muscle textures of a human body, so that the attachment of the apparatus provided by the utility model to the human body is ensured, and further, the treatment is more effectively carried out.
Drawings
FIG. 1 is a schematic perspective view of the present invention;
FIG. 2 is a schematic cross-sectional view of a control module according to the present invention;
FIG. 3 is a schematic front view of the present invention;
FIG. 4 is a schematic cross-sectional view of the electrode protection film according to the present invention.
In the figure: 1. a control module; 2. an electrode mechanism; 101. a main body housing; 102. a pulse circuit board; 103. a pulse controller; 104. a wireless communication module; 105. a first key; 106. a status indicator light; 107. a second key; 108. a third key; 201. an electrode sheet; 202. a connector contact; 203. and an electrode protection film.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
the utility model provides a technical scheme that: the wearable transcutaneous nerve electrical stimulation migraine therapeutic apparatus comprises a control module 1 and an electrode mechanism 2, wherein the electrode mechanism 2 is positioned at the lower side of the control module 1;
the control module 1 comprises a main body casing 101, a pulse circuit board 102, a pulse controller 103 and a wireless communication module 104, wherein the pulse circuit board 102 is fixedly arranged inside the main body casing 101, and the pulse circuit board 102 and the pulse controller 103 are arranged at the upper end of the pulse circuit board 102.
The pulse controller 103 is integrated with the wireless communication module 104, the wireless communication module 104 is a bluetooth communication module, and the device of the present invention can be controlled by an external device through a wireless communication channel, for example, a corresponding APP can be installed in a portable terminal such as a mobile phone, and the device of the present invention can be controlled by the APP, for example, the frequency, the width, the waveform, and the like of a pulse transmitted by the device are controlled.
The electrode mechanism 2 comprises an electrode sheet 201, a connector contact 202 and an electrode protection film 203, wherein the connector contact 202 is installed on the front surface of the electrode sheet 201, the connector contact 202 corresponds to a pulse emitting area of the electrode sheet 201, medical conductive gel is arranged on the pulse emitting area, the electrode sheet 201 is a PET electrode sheet, two pulse emitting button-type connector contacts 202 are arranged on the front surface of the electrode sheet 201, the medical conductive gel is attached to the skin of a human body when in use, the area is an area used for emitting pulses, the covered muscle area is an effective treatment area, and the pulse emitting contacts and the pulse emitting areas are not limited to the number specifically described above and can be other numbers.
In embodiment 1, the electrode sheet 201 has extremely low conductive resistance and good conductive performance, and can better adhere to the skin and muscle texture of the human body, ensuring the adhesion of the device of the present invention to the human body, and thus performing more effective treatment.
Example 2:
the electrode protection film 203 is positioned on the back surface of the electrode sheet 201, the electrode protection film 203 is tightly attached to the electrode sheet 201, and the attached electrode protection film 203 is used for protecting gel below the electrode sheet 201.
The frequency of the pulse controller 103 transmitting pulse circuit is within the range of 2-160Hz, the pulse controller 103 transmitting pulse circuit is bidirectional square wave electric wave with the width of 9-350us, certain low-frequency pulse electric stimulation can activate morphine polypeptide neuron in brain, and release of endogenous morphine-like polypeptide is caused to generate analgesic effect.
Example 2 is more complete than example 1, and the components cooperate with each other to adjust the therapeutic effect of the therapeutic apparatus.
Example 3:
the control module 1 further comprises a first key 105, a status indicator lamp 106, a second key 107, a third key 108 and a reset hole 109, the first key 105 is mounted at the upper end of the main body casing 101, the status indicator lamp 106 is located at the inner side of the first key 105, the power-on and power-off are controlled through the first key 105, the status indicator lamp 106 can indicate each status of the wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus, and the indicator lamp can be turned on when the wearable transcutaneous electrical nerve stimulation migraine therapeutic apparatus is powered on; when relieving muscle pain, the indicator light can be strobed; when the power-off is performed, the indicator light can be turned off, and when the power-on is performed, the indicator light changes color.
The second button 107 is installed at the side of the main body casing 101, the third button 108 is installed at the side of the main body casing 101, and the pulse intensity is adjusted by the second button 107 and the third button 108.
The first button 105 is electrically connected with the pulse circuit board 102, the status indicator lamp 106 is electrically connected with the pulse circuit board 102, the second button 107 is electrically connected with the pulse circuit board 102, the third button 108 is electrically connected with the pulse circuit board 102, the reset hole 109 is electrically connected with the pulse circuit board 102, and the connector contact 202 is electrically connected with the pulse circuit board 102.
The working principle is as follows: firstly tearing off the electrode protection film 203, attaching the wearable transcutaneous electrical nerve stimulation migraine treatment equipment to the head, then starting up by pressing the first key 105 for a long time, when the equipment is in a starting-up state, opening a small program or APP installed in external equipment (such as a portable terminal like a mobile phone), automatically establishing connection with the external equipment through the wireless communication module 104, and controlling the equipment in a state of being controlled through the external equipment, and automatically or manually controlling the intensity of pulse emission through the APP for 15-60 minutes; during the period, the pulse controller 103 of the pulse circuit board 102 controls the pulse circuit to output corresponding pulses, and after use, the first button 105 can be pressed for a long time to shut down the device, or in addition, the external device can be disconnected, and the pulse intensity can be directly adjusted to be increased or decreased through the second button 107 and the third button 108.
Finally, it should be noted that the above-mentioned contents are only used for illustrating the technical solutions of the present invention, and do not limit the protection scope of the present invention, and those skilled in the art can make simple modifications or equivalent substitutions on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (8)
1. Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument, including control module (1) and electrode mechanism (2), its characterized in that: the electrode mechanism (2) is positioned at the lower side of the control module (1);
the control module (1) comprises a main body shell (101), a pulse circuit board (102), a pulse controller (103) and a wireless communication module (104), wherein the pulse circuit board (102) is fixedly installed inside the main body shell (101), and the pulse circuit board (102) and the pulse controller (103) are installed at the upper end of the pulse circuit board (102).
2. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 1, wherein: the pulse controller (103) is integrated with a wireless communication module (104), and the wireless communication module (104) is a Bluetooth communication module.
3. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 2, wherein: the electrode mechanism (2) comprises an electrode plate (201), a connector contact (202) and an electrode protection film (203), wherein the connector contact (202) is installed on the front surface of the electrode plate (201).
4. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 3, wherein: the electrode protection film (203) is positioned on the back surface of the electrode plate (201), and the electrode protection film (203) is tightly attached to the electrode plate (201).
5. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 4, wherein: the frequency of a pulse circuit transmitted by the pulse controller (103) is in the range of 2-160Hz, and the pulse circuit transmitted by the pulse controller (103) is a bidirectional square wave electric wave with the width of 9-350 us.
6. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 5, wherein: the control module (1) further comprises a first key (105), a status indicator lamp (106), a second key (107), a third key (108) and a reset hole (109), the first key (105) is installed at the upper end of the main body shell (101), and the status indicator lamp (106) is located on the inner side of the first key (105).
7. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 6, wherein: the second key (107) is arranged on the side of the main body casing (101), and the third key (108) is arranged on the side of the main body casing (101).
8. The wearable transcutaneous electrical nerve stimulation migraine treatment apparatus of claim 7, wherein: the first key (105) is electrically connected with the pulse circuit board (102), the status indicator lamp (106) is electrically connected with the pulse circuit board (102), the second key (107) is electrically connected with the pulse circuit board (102), the third key (108) is electrically connected with the pulse circuit board (102), the reset hole (109) is electrically connected with the pulse circuit board (102), and the connector contact (202) is electrically connected with the pulse circuit board (102).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202122878292.7U CN216629424U (en) | 2021-11-23 | 2021-11-23 | Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202122878292.7U CN216629424U (en) | 2021-11-23 | 2021-11-23 | Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN216629424U true CN216629424U (en) | 2022-05-31 |
Family
ID=81736114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202122878292.7U Active CN216629424U (en) | 2021-11-23 | 2021-11-23 | Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN216629424U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114191714A (en) * | 2021-11-23 | 2022-03-18 | 北京新云医疗科技有限公司 | Wearable Transcutaneous Electrical Nerve Stimulation Migraine Therapy Device |
-
2021
- 2021-11-23 CN CN202122878292.7U patent/CN216629424U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114191714A (en) * | 2021-11-23 | 2022-03-18 | 北京新云医疗科技有限公司 | Wearable Transcutaneous Electrical Nerve Stimulation Migraine Therapy Device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001252069B2 (en) | Apparatus for electromedical therapy | |
| US9468759B2 (en) | Electrokinetic nerve stimulator | |
| CN109125921B (en) | Pulse acupuncture therapeutic instrument based on induced electroencephalogram signals | |
| US20140277323A1 (en) | Oral neural stimulator | |
| CN109718470A (en) | The In-Ear noninvasive nervus auricularis vagi stimulation instrument of one kind and its pulse output method | |
| CN113226452B (en) | Wave superposition type microcurrent biological application device | |
| CN216629424U (en) | Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument | |
| CN108721103A (en) | A kind of physiotherapy equipment of the low-frequency pulse acupoint therapy chronic pharyngitis based on Bluetooth communication | |
| CN108434595A (en) | A kind of head-type brain electric stimulating instrument and its electrical stimulation method | |
| US20050187497A1 (en) | Electrical impulse apparatus for facial massage | |
| KR20120029969A (en) | Portable low frequency massager device | |
| CN220530504U (en) | A wearable scoliosis rehabilitation fabric and device | |
| CN114191714A (en) | Wearable Transcutaneous Electrical Nerve Stimulation Migraine Therapy Device | |
| CN218636444U (en) | Transcranial micro-current stimulation sleeping instrument capable of playing 40Hz music | |
| EP1911491A1 (en) | Healthcare device for electrostimulation | |
| CN109481298A (en) | A kind of delay electro-acupuncture needle and its drive control module | |
| KR100409100B1 (en) | Electrical Stimulator using Mobile Phone | |
| CN204671737U (en) | Intermediate frequency physiotherapy table | |
| KR20220099781A (en) | Flexible conductor Polymer Microcurrent Patch | |
| CN219332953U (en) | Percutaneous nerve electric stimulator capable of improving use tolerance | |
| CN113018685A (en) | Network addiction therapeutic apparatus | |
| CN209713996U (en) | A kind of In-Ear noninvasive nervus auricularis vagi stimulation instrument | |
| CN221431925U (en) | Meridian electric stimulation therapeutic instrument | |
| CN219022192U (en) | a massager | |
| CN215230282U (en) | Electric acupuncture rehabilitation therapeutic apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |